Variant report
Variant | nsv961349 |
---|---|
Chromosome Location | chr2:123827896-123840926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:123831015-123831299 | HepG2 | liver: | n/a | chr2:123831126-123831137 |
2 | CEBPB | chr2:123830989-123831302 | K562 | blood: | n/a | chr2:123831126-123831137 |
3 | CHD2 | chr2:123837884-123838184 | GM12878 | blood: | n/a | n/a |
4 | CTCF | chr2:123831440-123831590 | HepG2 | liver: | n/a | n/a |
5 | CUX1 | chr2:123839834-123839840 | GM12878 | blood: | n/a | n/a |
6 | E2F4 | chr2:123830983-123831225 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | EBF1 | chr2:123840812-123840987 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr2:123837901-123838324 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr2:123837920-123838267 | GM12878 | blood: | n/a | n/a |
10 | FOS | chr2:123837902-123838279 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr2:123831041-123831270 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr2:123837882-123838243 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr2:123830986-123831329 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOS | chr2:123830966-123831292 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | FOS | chr2:123837917-123838277 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr2:123837976-123838246 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr2:123830974-123831341 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOXA1 | chr2:123834745-123835000 | T-47D | breast: | n/a | n/a |
19 | FOXA1 | chr2:123834636-123834953 | T-47D | breast: | n/a | n/a |
20 | GATA3 | chr2:123834607-123834993 | T-47D | breast: | n/a | n/a |
21 | GATA3 | chr2:123834683-123835049 | T-47D | breast: | n/a | n/a |
22 | GATA3 | chr2:123837551-123837631 | SH-SY5Y | brain: | n/a | n/a |
23 | GATA3 | chr2:123834756-123835001 | MCF-7 | breast: | n/a | n/a |
24 | MAFK | chr2:123832812-123832975 | HepG2 | liver: | n/a | chr2:123832864-123832879 |
25 | MAFK | chr2:123832816-123832956 | HepG2 | liver: | n/a | chr2:123832864-123832879 |
26 | MAZ | chr2:123828005-123828046 | HepG2 | liver: | n/a | n/a |
27 | MYC | chr2:123831159-123831347 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | MYC | chr2:123839306-123839452 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | NRF1 | chr2:123830821-123830930 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | POLR2A | chr2:123830764-123831258 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr2:123837243-123837396 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr2:123831036-123831288 | U87 | brain: | n/a | n/a |
33 | POLR2A | chr2:123839291-123839320 | Gliobla | brain: | n/a | n/a |
34 | POLR2A | chr2:123839241-123839267 | MCF-7 | breast: | n/a | n/a |
35 | SIN3A | chr2:123837933-123838052 | GM12878 | blood: | n/a | n/a |
36 | SPI1 | chr2:123831547-123831967 | HL-60 | blood: | n/a | n/a |
37 | SPI1 | chr2:123831638-123832034 | HL-60 | blood: | n/a | n/a |
38 | STAT3 | chr2:123831046-123831246 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | STAT3 | chr2:123838086-123838175 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | STAT3 | chr2:123838043-123838233 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:123828454..123831297-chr2:123833230..123835913,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MKI67IP-3 | chr2:123827743-123827940 | XLOC_002303 |
2 | lnc-MKI67IP-3 | chr2:123830728-123831057 | XLOC_002303 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232740 | TF binding region |
ENSG00000232740 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17009319 | chr2:123827900-123827901 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs559264457 | chr2:123827911-123827912 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs299538 | chr2:123827926-123827927 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs545072097 | chr2:123827946-123827947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546290542 | chr2:123828000-123828001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1515164 | chr2:123828017-123828018 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs180672690 | chr2:123828183-123828184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567372296 | chr2:123828185-123828186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529965865 | chr2:123828234-123828235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6541878 | chr2:123828250-123828251 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs566457991 | chr2:123828278-123828279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191157797 | chr2:123828313-123828314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368438069 | chr2:123828368-123828369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13033813 | chr2:123828369-123828370 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs5833971 | chr2:123828388-123828389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113197455 | chr2:123828389-123828390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558566545 | chr2:123828413-123828414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185104560 | chr2:123828418-123828419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs299537 | chr2:123828431-123828432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs13033509 | chr2:123828452-123828453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs13033663 | chr2:123828463-123828464 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs370946923 | chr2:123828468-123828469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554146633 | chr2:123828521-123828522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13010429 | chr2:123828548-123828549 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs534273847 | chr2:123828549-123828550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs299536 | chr2:123828559-123828560 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs533778223 | chr2:123828614-123828615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13010613 | chr2:123828616-123828617 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs115615906 | chr2:123828620-123828621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564549819 | chr2:123828625-123828626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528630202 | chr2:123828658-123828659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374902002 | chr2:123828685-123828686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148035929 | chr2:123828688-123828689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13010816 | chr2:123828696-123828697 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs142523047 | chr2:123828709-123828710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191143868 | chr2:123828723-123828724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542042949 | chr2:123828747-123828748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183449402 | chr2:123828750-123828751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12620936 | chr2:123828759-123828760 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs538301012 | chr2:123828760-123828761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541080061 | chr2:123828800-123828801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58936843 | chr2:123828831-123828832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554747284 | chr2:123828852-123828853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13011089 | chr2:123828854-123828855 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs35870013 | chr2:123828873-123828874 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs369239388 | chr2:123828928-123828929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114406023 | chr2:123828989-123828990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577569392 | chr2:123828995-123828996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546544045 | chr2:123829016-123829017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116464838 | chr2:123829020-123829021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:123827600-123829200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:123827800-123828800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:123828800-123829800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:123829200-123829800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr2:123829800-123831800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr2:123830200-123830800 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr2:123830800-123831000 | Flanking Active TSS | Primary monocytes fromperipheralblood | blood |
8 | chr2:123831000-123832800 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr2:123831200-123832400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr2:123831200-123832600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr2:123831800-123832000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr2:123836800-123837400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:123838400-123839400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr2:123839000-123839400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr2:123839000-123839400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr2:123839000-123839400 | Enhancers | NH-A | brain |
17 | chr2:123839200-123839800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr2:123839400-123844200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |